Literature DB >> 19575365

Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.

Alessia Omenetti1, Wing-Kin Syn, Youngmi Jung, Heather Francis, Alessandro Porrello, Rafal P Witek, Steve S Choi, Liu Yang, Marlyn J Mayo, M Eric Gershwin, Gianfranco Alpini, Anna Mae Diehl.   

Abstract

UNLABELLED: The mechanisms mediating hepatic accumulation of inflammatory cells in cholestatic liver disease remain enigmatic. Our thesis is that Hedgehog (Hh) pathway activation promotes hepatic accumulation of immune cells that interact with cholangiocytes. We believe that myofibroblastic hepatic stellate cells (MF-HSCs) release soluble Hh ligands that stimulate cholangiocytes to express chemokines that recruit mononuclear cell types with cognate receptors for these chemokines, thereby orchestrating a repair-related mechanism for liver inflammation. To address this thesis, we used three experimental systems that allow the definition of Hh-dependent mechanisms that induce phenotypic changes in cholangiocytes. First, cholangiocytes were cultured alone or in the presence of Hh-producing MF-HSCs in a transwell coculture system and/or treated with MF-HSC-conditioned medium with or without Hh-neutralizing antibodies. Changes in the cholangiocyte phenotype were then evaluated by microarray analysis, quantitative reverse-transcriptase polymerase chain reaction (QRT-PCR), and/or enzyme-linked immunosorbent assay for chemokine (C-X-C) motif ligand 16 (Cxcl16). Bile duct ligation was chosen to model biliary fibrosis in mice with an overly active Hh pathway, control littermates, and healthy rats, and the gene profile was evaluated by QRT-PCR in whole liver tissue. Second, a transwell chemotaxis assay was used to examine natural killer T (NKT) cell migration in response to cholangiocytes and particularly cholangiocyte-derived Cxcl16. Finally, we studied liver samples from primary biliary cirrhosis patients and controls by QRT-PCR to compare differences in the Hh pathway and Cxcl16. Co-immunostaining of cytokeratin-7 and Cxcl16 was then performed to localize the phenotypic source of Cxcl16. We found that MF-HSCs release soluble Hh ligands that stimulate cholangiocytes to produce Cxcl16 and recruit NKT cells. Hh pathway activation during cholestatic liver injury also induces cholangiocyte expression of Cxcl16.
CONCLUSION: During biliary injury, Hh pathway activation induces cholangiocyte production of chemokines that recruit NKT cells to portal tracts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575365      PMCID: PMC2722691          DOI: 10.1002/hep.23019

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  55 in total

Review 1.  Transducing the hedgehog signal.

Authors:  D Kalderon
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

2.  Creating the gene ontology resource: design and implementation.

Authors: 
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

3.  Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential.

Authors:  C H Kim; E J Kunkel; J Boisvert; B Johnston; J J Campbell; M C Genovese; H B Greenberg; E C Butcher
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding.

Authors:  Fang Liao; Aiko-Konno Shirakawa; John F Foley; Ronald L Rabin; Joshua M Farber
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver.

Authors:  Y Shimizu; H Murata; Y Kashii; K Hirano; H Kunitani; K Higuchi; A Watanabe
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

6.  Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells.

Authors:  R Krzysiek; E A Lefevre; J Bernard; A Foussat; P Galanaud; F Louache; Y Richard
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

7.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo.

Authors:  M Matloubian; A David; S Engel; J E Ryan; J G Cyster
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

Review 8.  Chemokines in liver inflammation and fibrosis.

Authors:  Fabio Marra
Journal:  Front Biosci       Date:  2002-09-01

9.  Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans.

Authors:  Youngmi Jung; Kevin D Brown; Rafal P Witek; Alessia Omenetti; Liu Yang; Margon Vandongen; Richard J Milton; Ian N Hines; Richard A Rippe; Laurent Spahr; Laura Rubbia-Brandt; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

10.  The hedgehog pathway regulates remodelling responses to biliary obstruction in rats.

Authors:  A Omenetti; Y Popov; Y Jung; S S Choi; R P Witek; L Yang; K D Brown; D Schuppan; A M Diehl
Journal:  Gut       Date:  2008-03-28       Impact factor: 23.059

View more
  54 in total

1.  Suppression of hedgehog signaling regulates hepatic stellate cell activation and collagen secretion.

Authors:  Tao Li; Xi-Sheng Leng; Ji-Ye Zhu; Gang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Gastric Sonic Hedgehog acts as a macrophage chemoattractant during the immune response to Helicobacter pylori.

Authors:  Michael A Schumacher; Jessica M Donnelly; Amy C Engevik; Chang Xiao; Li Yang; Susan Kenny; Andrea Varro; Frédéric Hollande; Linda C Samuelson; Yana Zavros
Journal:  Gastroenterology       Date:  2012-01-25       Impact factor: 22.682

Review 3.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

Review 4.  Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.

Authors:  Juanita L Merchant; Milena Saqui-Salces
Journal:  Cancer Treat Rev       Date:  2013-08-13       Impact factor: 12.111

5.  Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Herbert Pang; Cynthia D Guy; Alastair D Smith; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 6.  Role of liver progenitors in liver regeneration.

Authors:  Jan Best; Paul Manka; Wing-Kin Syn; Laurent Dollé; Leo A van Grunsven; Ali Canbay
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

7.  NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.

Authors:  Wing-Kin Syn; Kolade M Agboola; Marzena Swiderska; Gregory A Michelotti; Evaggelia Liaskou; Herbert Pang; Guanhua Xie; George Philips; Isaac S Chan; Gamze F Karaca; Thiago de Almeida Pereira; Yuping Chen; Zhiyong Mi; Paul C Kuo; Steve S Choi; Cynthia D Guy; Manal F Abdelmalek; Anna Mae Diehl
Journal:  Gut       Date:  2012-03-17       Impact factor: 23.059

Review 8.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

9.  Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.

Authors:  Steve S Choi; Lee C Claridge; Ravi Jhaveri; Marzena Swiderska-Syn; Paul Clark; Ayako Suzuki; Thiago A Pereira; Zhiyong Mi; Paul C Kuo; Cynthia D Guy; Fausto E L Pereira; Anna Mae Diehl; Keyur Patel; Wing-Kin Syn
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

10.  Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.

Authors:  Rance Nault; Kelly A Fader; Dustin A Ammendolia; Peter Dornbos; Dave Potter; Bonnie Sharratt; Kazuyoshi Kumagai; Jack R Harkema; Sophia Y Lunt; Jason Matthews; Tim Zacharewski
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.